The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
Thus far, Pfizer's obesity efforts have crashed and burned. Last year, the pharmaceutical giant threw in the towel on ...
Considerable on MSN
Lilly’s Zepbound seen beating Pfizer injection
Eli Lilly’s Zepbound is still viewed as the leading weight-loss shot, according to a ...
By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results